MDS expert Valeria Santini, MD, of the University of Florence, advises patients to ask their doctor which
genetic tests are available for suspected
myelodysplastic syndromes (
MDS). Karyotype testing for
chromosomal abnormalities in MDS is essential, as is
genetic testing that can find a wide array of mutations, including less common ones. Patients should ask about testing to look for new mutations during and after treatment so treatment can be adjusted if necessary.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.